627 related articles for article (PubMed ID: 22760290)
1. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.
Zhang J; Xie F; Delzell E; Chen L; Winthrop KL; Lewis JD; Saag KG; Baddley JW; Curtis JR
JAMA; 2012 Jul; 308(1):43-9. PubMed ID: 22760290
[TBL] [Abstract][Full Text] [Related]
2. The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.
Zhang J; Delzell E; Xie F; Baddley JW; Spettell C; McMahan RM; Fernandes J; Chen L; Winthrop K; Curtis JR
Arthritis Res Ther; 2011; 13(5):R174. PubMed ID: 22024532
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older.
Izurieta HS; Wernecke M; Kelman J; Wong S; Forshee R; Pratt D; Lu Y; Sun Q; Jankosky C; Krause P; Worrall C; MaCurdy T; Harpaz R
Clin Infect Dis; 2017 Mar; 64(6):785-793. PubMed ID: 28362955
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States.
Lu A; Sun Y; Porco TC; Arnold BF; Acharya NR
Ophthalmology; 2021 Dec; 128(12):1699-1707. PubMed ID: 33892049
[TBL] [Abstract][Full Text] [Related]
5. Longterm Effectiveness of Herpes Zoster Vaccine among Patients with Autoimmune and Inflammatory Diseases.
Yun H; Xie F; Baddley JW; Winthrop K; Saag KG; Curtis JR
J Rheumatol; 2017 Jul; 44(7):1083-1087. PubMed ID: 28298565
[TBL] [Abstract][Full Text] [Related]
6. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster.
Winthrop KL; Baddley JW; Chen L; Liu L; Grijalva CG; Delzell E; Beukelman T; Patkar NM; Xie F; Saag KG; Herrinton LJ; Solomon DH; Lewis JD; Curtis JR
JAMA; 2013 Mar; 309(9):887-95. PubMed ID: 23462785
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases.
Khan N; Trivedi C; Kavani H; Medvedeva E; Lewis J; Yang YX
Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1341-1347. PubMed ID: 30326303
[TBL] [Abstract][Full Text] [Related]
8. Vaccination against zoster remains effective in older adults who later undergo chemotherapy.
Tseng HF; Tartof S; Harpaz R; Luo Y; Sy LS; Hetcher RC; Jacobsen SJ
Clin Infect Dis; 2014 Oct; 59(7):913-9. PubMed ID: 25097079
[TBL] [Abstract][Full Text] [Related]
9. Herpes Zoster Vaccine Live and Risk of Stroke Among Medicare Beneficiaries: A Population-Based Cohort Study.
Yang Q; Chang A; Tong X; Merritt R
Stroke; 2021 May; 52(5):1712-1721. PubMed ID: 33874749
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine.
Tseng HF; Smith N; Sy LS; Jacobsen SJ
Vaccine; 2011 May; 29(20):3628-32. PubMed ID: 21435407
[TBL] [Abstract][Full Text] [Related]
11. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease.
Tseng HF; Smith N; Harpaz R; Bialek SR; Sy LS; Jacobsen SJ
JAMA; 2011 Jan; 305(2):160-6. PubMed ID: 21224457
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease.
Tseng HF; Luo Y; Shi J; Sy LS; Tartof SY; Sim JJ; Hechter RC; Jacobsen SJ
Clin Infect Dis; 2016 Feb; 62(4):462-7. PubMed ID: 26671505
[TBL] [Abstract][Full Text] [Related]
13. Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study.
Langan SM; Smeeth L; Margolis DJ; Thomas SL
PLoS Med; 2013; 10(4):e1001420. PubMed ID: 23585738
[TBL] [Abstract][Full Text] [Related]
14. Clinical effectiveness of zoster vaccine live in kidney transplant recipients immunized prior to transplantation: a retrospective single-centre cohort study.
Kim SH; Huh K; Lee KW; Park JB; Huh WS; Ko JH; Cho SY; Kang CI; Chung DR; Peck KR
Clin Microbiol Infect; 2023 Jul; 29(7):911-917. PubMed ID: 36868356
[TBL] [Abstract][Full Text] [Related]
15. Safety of live attenuated varicella-zoster vaccine in patients with underlying illnesses compared with healthy adults: a prospective cohort study.
Ohfuji S; Ito K; Inoue M; Ishibashi M; Kumashiro H; Hirota Y; Kayano E; Ota N
BMC Infect Dis; 2019 Jan; 19(1):95. PubMed ID: 30691396
[TBL] [Abstract][Full Text] [Related]
16. Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination.
Yun H; Yang S; Chen L; Xie F; Winthrop K; Baddley JW; Saag KG; Singh J; Curtis JR
Arthritis Rheumatol; 2016 Sep; 68(9):2328-37. PubMed ID: 26990731
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine.
Grupping K; Campora L; Douha M; Heineman TC; Klein NP; Lal H; Peterson J; Vastiau I; Oostvogels L
J Infect Dis; 2017 Dec; 216(11):1343-1351. PubMed ID: 29029122
[TBL] [Abstract][Full Text] [Related]
18. Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries.
Goud R; Lufkin B; Duffy J; Whitaker B; Wong HL; Liao J; Lo AC; Parulekar S; Agger P; Anderson SA; Wernecke M; MaCurdy TE; Weintraub E; Kelman JA; Forshee RA
JAMA Intern Med; 2021 Dec; 181(12):1623-1630. PubMed ID: 34724025
[TBL] [Abstract][Full Text] [Related]
19. Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti-TNF medications.
Khan N; Shah Y; Trivedi C; Lewis JD
Aliment Pharmacol Ther; 2017 Oct; 46(7):668-672. PubMed ID: 28805309
[TBL] [Abstract][Full Text] [Related]
20. Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy.
Yun H; Xie F; Delzell E; Chen L; Levitan EB; Lewis JD; Saag KG; Beukelman T; Winthrop K; Baddley JW; Curtis JR
Arthritis Care Res (Hoboken); 2015 May; 67(5):731-6. PubMed ID: 25201241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
